Latest CSL Limited Stories
KING OF PRUSSIA, Pa., May 18 /PRNewswire/ -- CSL Behring announced today the schedule for its 9th annual Gettin' in the Game(SM) Junior National Championship (JNC) competition in golf and baseball. The JNC is a series of one-day athletic events for children with bleeding disorders, such as hemophilia or von Willebrand disease (VWD), and their families. During the JNC young people with a bleeding disorder have the opportunity to connect with and compete against others who have these...
SANTA BARBARA, Calif., May 14 /PRNewswire/ -- Direct Relief International announced today that CSL Behring has donated life-saving medicines valued at more than $100,000 to assist earthquake victims in Haiti who are at risk of tetanus or hepatitis B infections. The products will be used in clinics at Hopital Albert Schweitzer in Deschapelles. The donation, consisting of 5,000 syringes of Tetagam® P and 600 5ml ampoules of Hepatitis B Immunoglobulin, will help treat patients who have...
AUSTIN, Texas, May 13 /PRNewswire/ -- To promote the importance of screening young women for von Willebrand disease (VWD), the American Academy of Nurse Practitioners (AANP) today announced the launch of its VWD Young Women's Education Campaign. This educational initiative is designed to inform teenage girls and their healthcare providers about the five signs and symptoms of VWD, the most common hereditary bleeding disorder. To view the multimedia assets associated with this release,...
KING OF PRUSSIA, Pa., April 19 /PRNewswire/ -- CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) to extend the shelf life for Privigen®, Immune Globulin Intravenous (Human), 10% Liquid, from 24 to 36 months. The approval makes Privigen the first liquid intravenous immunoglobulin (IVIg) in the U.S. that can be stored at room temperature throughout its entire 36-month shelf life. Privigen is the...
KING OF PRUSSIA, Pa. and MONTREAL, April 16 /PRNewswire/ -- Hemophilia B patients in the developing world will benefit from a recent donation of 1 million international units (IU) of factor IX medication made by CSL Behring to the World Federation of Hemophilia (WFH). The donation, channeled through WFH's United Kingdom chapter, marks World Hemophilia Day 2010 and will support WFH's progress in improving the diagnosis and treatment of hemophilia in developing countries through its Global...
SAN DIEGO, March 22 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that Brian McNamee, MBBS, CEO and managing director of the leading international biopharmaceutical company CSL Ltd., has been elected to its board of directors. Gen-Probe's board now has nine members, including seven independent directors. "We are delighted that Brian has agreed to re-join Gen-Probe's already strong board," said Hank Nordhoff, the Company's chairman. "We are sure to benefit...
NEW ORLEANS, March 1 /PRNewswire/ -- C1-esterase inhibitor (C1-INH) concentrate is an effective, well-tolerated therapy that rapidly relieves acute swelling attacks and successive attacks at any body location in patients with hereditary angioedema (HAE), a rare and serious genetic disorder, according to data presented today at the 2010 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting. Additional pharmacokinetic data presented at the meeting confirms that C1-INH...
NEW ORLEANS, March 1 /PRNewswire/ -- Patients with hereditary angioedema (HAE) experience prodromal or early warning symptoms before nearly three-quarters of their HAE attacks, according to survey findings presented today at the 2010 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting. According to researchers, this high frequency suggests that prodromal symptoms may reliably indicate when to initiate treatment to help prevent an acute HAE attack. To identify the...
BARCELONA, Spain, Feb. 15 /PRNewswire-FirstCall/ -- At GSMA's Mobile World Congress, Amdocs (NYSE: DOX), the leading provider of customer experience systems, today announced that CSL Limited (CSL), Hong Kong's leading mobile operator, has chosen an Amdocs ChangingWorlds solution to support its new, innovative mobile Internet service, MyNet. CSL last year launched its award-winning All-IP Next G(TM) network in Hong Kong. With its high speed and enhanced capacity, this network offers...
KING OF PRUSSIA, Pa., Jan. 27 /PRNewswire/ -- CSL Behring announced today the launch of the Berinert® Expert Network (B.E.N.(TM)), a full-service support program for healthcare providers and for hereditary angioedema (HAE) patients and their caregivers. HAE is a rare and serious disorder that causes swelling in various parts of the body. In October the U.S. Food and Drug Administration (FDA) granted marketing approval for Berinert C1-Esterase Inhibitor, Human for the treatment of acute...
